Does dengue and COVID-19 co-infection have worse outcomes? A systematic review of current evidence
- PMID: 35213764
- PMCID: PMC9111070
- DOI: 10.1002/rmv.2339
Does dengue and COVID-19 co-infection have worse outcomes? A systematic review of current evidence
Abstract
In dengue-endemic regions, the co-infection with SARS-CoV-2 and dengue is a significant health concern. Therefore, we performed a literature search for relevant papers in seven databases on 26 Spetember 2021. Out of 24 articles, the mortality rate and intensive care unit (ICU) admission were 19.1% and 7.8%, respectively. The mean hospital stay was 11.4 days. In addition, we identified two pregnancies with dengue and COVID-19 co-infection; one ended with premature rupture of membrane and intrauterine growth restriction fetus, while the other one ended with maternal mortality and intrauterine fetal death. COVID-19 and dengue co-infection had worse outcomes regarding mortality rates, ICU admission, and prolonged hospital stay. Thus, wise-decision management approaches should be adequately offered to these patients to enhance their outcomes. Establishing an early diagnosis might be the answer to reducing the estimated significant burden of these conditions.
Keywords: COVID-19; SARS-CoV-2; co-infection; dengue; systematic review.
© 2022 John Wiley & Sons Ltd.
Conflict of interest statement
None.
Figures
References
-
- Tian Y‐S, Zhou Y, Takagi T, Kameoka M, Kawashita N. Dengue virus and its inhibitors: a brief review. Chem Pharm Bull. 2018;66(3):191‐206. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
